- All sections
- C - Chemistrymetallurgy
- C07H - Sugarsderivatives thereofnucleosidesnucleotidesnucleic acids
- C07H 15/23 - Cyclohexane rings, substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin
Patent holdings for IPC class C07H 15/23
Total number of patents in this class: 33
10-year publication summary
|
2
|
6
|
7
|
3
|
3
|
5
|
3
|
1
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Eloxx Pharmaceuticals Ltd. | 18 |
14 |
| Technion Research & Development Foundation Ltd. | 1205 |
8 |
| Glaxosmithkline Intellectual Property Development Limited | 738 |
1 |
| Beijing University of Chemical Technology | 312 |
1 |
| Dionex Corporation | 326 |
1 |
| GlycoMimetics, Inc. | 125 |
1 |
| Isis Pharmaceuticals, Inc. | 220 |
1 |
| PTC Therapeutics, Inc. | 469 |
1 |
| Rijksuniversiteit Groningen | 272 |
1 |
| Universitat Zurich | 634 |
1 |
| Wayne State University | 680 |
1 |
| Fimbrion Therapeutics, Inc. | 15 |
1 |
| Glycosynnovations Pty Ltd | 8 |
1 |
| Other owners | 0 |